media – Page 478 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Johnson & Johnson Sells Calibra Diabetic Product to Cequr

Johnson & Johnson is moving out from the diabetes business and sold its Calibra product (marketed as OneTouch Via, but never launched) to a 10-year-old company named CeQur, which was already working on a similar insulin-delivery wearable. The terms and conditions of this deal have not yet been yet disclosed, but CeQur has attained an exclusive worldwide license for this technology.
- Source: MobiHealthNews
- 824
- July 19, 2018
Company Insight diabetes wearables
Recent Study Reports on Liver Cancer Risks and Detection

HCC or hepatocellular carcinoma can result in patients getting liver diseases such as viral hepatitis and non-alcoholic fatty liver disease with cirrhosis due to disease progression. New data from recent researches shows factors that improve early detection and diagnosis, and risks prior to HCC and during treatment.
- Source: Healio
- 566
- July 19, 2018
liver cancer Researches
Spero Gets Grant of $54M for Biodefense R&D for SPR994

Spero Therapeutics granted $15.7 million for research on SPR994, its oral carbapenem-class candidate, to study the drug’s efficacy against biological threats like anthrax, plague and melioidosis as a part of an interagency collaboration.
- Source: FierceBiotech
- 806
- July 18, 2018
biotech Company Insight
Hidden Blood in Stool Could Predict Fatal Health Conditions

If a drop of blood is seen in stool, people tend to panic. The causative factors could include digestive, respiratory, circulatory, hematological or even neuropsychological diseases.
- Source: MedicalXpress
- 693
- July 18, 2018
bowel cancer Researches
Verge Genomics Raised $32 Million for Clinical Trial Work of AI Based Neuroscience Drugs

San Francisco based Verge Genomics, the Neuroscience based drug discovery company launched in 2015, has raised $32 million in early venture capital financing to bring its AI-generated compounds against Parkinson’s disease and amyotrophic lateral sclerosis (ALS) to clinics within the next three years.
- Source: FierceBiotech
- 672
- July 18, 2018
AI Company Insight digital health
Do Mental Health Apps Under-Diagnose or Over-Diagnose?

A digital era in the medical field has arisen where one could find the increased utilization of health apps. But a recent analysis by a research team from the University of Sydney in Australia claims that these apps might lead to insignificant diagnosis and wrong information about the illness.
- Source: MobiHealthNews
- 916
- July 18, 2018
Mental health mHealth Researches
TREAT-B – Blood Test to Detect Hepatitis B Well in Advance

Viral hepatitis is a major global health issue since it is the seventh leading cause of death worldwide. Around half of hepatitis-related deaths reported are due to the hepatitis B virus infection, which is transmitted through blood and body fluids.
- Source: MedIndia
- 405
- July 18, 2018
blood test hepatitis B Researches
Key Safety Data Missing From Probiotics RCTs

A systematic review revealed the inadequacy of adverse event data in clinical trials of probiotics and prebiotics, rendering it difficult to draw broad conclusions with regards to the safety of interventions to modify gut micro-organisms. These randomized trials assessed probiotics, prebiotics, or synbiotics, which are products that combine probiotics and probiotics.
- Source: International Medicine News
- 728
- July 18, 2018
Prebiotics Probiotics Researches
Innovation Contest for Certified Health IT Product List Data by ONC

The Office of the National Coordinator for Health IT which introduced The Certified Health IT Product List Data Challenge in the last week, has initiated a contest for innovative ideas that highlights how its vast and meticulous specs can enhance service to hospitals and health systems.
- Source: HealthcareIT News
- 631
- July 18, 2018
digital health health IT Market Views
Care Quality Commission Rates Digital GP Centre in Birmingham ‘Outstanding’

The CQC rated the South Doc Services Limited as ‘outstanding’ in a report on 11 July. The service operates virtual primary care services for the MyHealthcare GP federation, functioning at several hubs across Birmingham with more than 47 GP practices under its umbrella catering to around 300,000 registered patients. The report praised how the “service used technology to improve treatment and to support patients’ independence”.
- Source: DigitalHealth
- 672
- July 18, 2018
Company Insight digital health

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.